Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0T2LR
|
|||
| Former ID |
DIB002655
|
|||
| Drug Name |
PMX-30063
|
|||
| Synonyms |
PolyCide compounds; PMX-085; PMX-100; PMX-223; PMX-243; PMX-519; Small-molecule defense protein mimetic antibiotics, PolyMedix; Defensin mimetic antibiotic (oral, bacterial infections), PolyMedix; Defensin mimetic antibiotic (topical oral rinse, oral mucositis), PolyMedix; PMX-30063 (oral, Clostridium difficile infection), PolyMedix; PMX-30063 (oral, bacterial infections), PolyMedix; PMX-30063 (topical ophthalmic, bacterial infections), Polymedix; PMX-30063 (topical oral rinse, oral mucositis), PolyMedix; Small molecule defense portein mimetic antibiotics (ophthalmic/topical formulation, bacterial infection), Polymedix
Click to Show/Hide
|
|||
| Indication | Oral mucositis [ICD-11: DA01.11; ICD-10: K12.3; ICD-9: 528] | Phase 2 | [1] | |
| Company |
PolyMedix Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01211470) Initial Treatment for Acute Bacterial Skin Infections (ABSSSI) Caused by Staphylococcus Aureus. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.